β-Adrenergic receptor stimulation and activation of protein kinase A protect against α 1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5

Journal of Cardiac Failure

Volumn 17, Issue 7, 2011, Pages 592-600

  Sucharov, Carmen C ^a   Dockstader, Karen ^a   Nunley, Karin ^a   McKinsey, Timothy A ^a   Bristow, Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiac hypertrophy; fetal gene program; phosphatase; PP2A

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CONTRACTILE PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HISTONE DEACETYLASE 5; ISOPRENALINE; PROTEIN KINASE D;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CARDIOMYOPATHY; DOWN REGULATION; ENZYME ACTIVITY; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; HISTONE DEACETYLASES; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 79959563346     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.03.006     Document Type: Article

References (31)

1. M.R. Bristow Mechanism of action of beta-blocking agents in heart failure Am J Cardiol 80 11A 1997 26L 40L (Pubitemid 27528445)
2. M. Esler, D. Kaye, G. Lambert, D. Esler, and G. Jennings Adrenergic nervous system in heart failure Am J Cardiol 80 11A 1997 7L 14L (Pubitemid 27528443)
3. B.D. Lowes, E.M. Gilbert, W.T. Abraham, W.A. Minobe, P. Larrabee, and D. Ferguson Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N Engl J Med 346 2002 1357 1365 (Pubitemid 34754608)
4. C.C. Sucharov, P.D. Mariner, K.R. Nunley, C. Long, L. Leinwand, and M.R. Bristow A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction Am J Physiol Heart Circ Physiol 291 2006 H1299 H1308
5. J. Mialet Perez, D.A. Rathz, N.N. Petrashevskaya, H.S. Hahn, L.E. Wagoner, and A. Schwartz Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure Nat Med 9 2003 1300 1305 (Pubitemid 37279854)
6. C. Morisco, D.C. Zebrowski, D.E. Vatner, S.F. Vatner, and J. Sadoshima Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart J Mol Cell Cardiol 33 2001 561 573 (Pubitemid 32539011)
7. M.J. Lohse, S. Engelhardt, and T. Eschenhagen What is the role of beta-adrenergic signaling in heart failure? Circ Res 93 2003 896 906 (Pubitemid 37433227)
8. 2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts Cardiovasc Res 42 1999 254 261 (Pubitemid 29167092)
9. M.R. Bristow, and A.M. Feldman Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease Basic Res Cardiol 87 Supp 1 1992 15 35
10. R.H. Schwinger, G. Munch, B. Bolck, P. Karczewski, E.G. Krause, and E. Erdmann Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serine-16 phospholamban phosphorylation J Mol Cell Cardiol 31 1999 479 491 (Pubitemid 29121635)
11. S.O. Marx, S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff, and N. Rosemblit PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 101 2000 365 376
12. K. Asai, G.P. Yang, Y.J. Geng, G. Takagi, S. Bishop, and Y. Ishikawa Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse J Clin Invest 104 1999 551 558
13. B. Xiao, G. Zhong, M. Obayashi, D. Yang, K. Chen, and M.P. Walsh Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts Biochem J 396 2006 7 16 (Pubitemid 43764491)
14. N.A. Benkusky, C.S. Weber, J.A. Scherman, E.F. Farrell, T.A. Hacker, and M.C. John Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor Circ Res 101 2007 819 829 (Pubitemid 350287197)
15. M.B. Calalb, T.A. McKinsey, S. Newkirk, K. Huynh, C.C. Sucharov, and M.R. Bristow Increased phosphorylation-dependent nuclear export of class II histone deacetylases in failing human heart Clin Transl Sci 2 2009 325 332
16. R.S. Haworth, N.A. Roberts, F. Cuello, and M. Avkiran Regulation of protein kinase D activity in adult myocardium: novel counter-regulatory roles for protein kinase cepsilon and protein kinase A J Mol Cell Cardiol 43 2007 686 695 (Pubitemid 350166389)
17. R.S. Haworth, F. Cuello, and M. Avkiran Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation Basic Res Cardiol 106 2011 51 63
18. G. Thiel, M. Lietz, and M. Hohl How mammalian transcriptional repressors work Eur J Biochem 271 2004 2855 2862 (Pubitemid 38980272)
19. L.E. Waspe, C.P. Ordahl, and P.C. Simpson The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes J Clin Invest 85 1990 1206 1214 (Pubitemid 20123764)
20. C.C. Sucharov, K. Dockstader, and T.A. McKinsey YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5 Mol Biol Cell 19 2008 4141 4153
21. C.A. Emter, S.A. McCune, G.C. Sparagna, M.J. Radin, and R.L. Moore Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats Am J Physiol Heart Circ Physiol 289 2005 H2030 H2038
22. C.C. Sucharov, P. Mariner, C. Long, M. Bristow, and L. Leinwand Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter J Biol Chem 278 2003 31233 31239 (Pubitemid 36994640)
23. J.H. Ahn, T. McAvoy, S.V. Rakhilin, A. Nishi, P. Greengard, and A.C. Nairn Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit Proc Natl Acad Sci U S A 104 2007 2979 2984 (Pubitemid 46327989)
24. K. Singh, C. Communal, and W.S. Colucci Inhibition of protein phosphatase 1 induces apoptosis in neonatal rat cardiac myocytes: role of adrenergic receptor stimulation Basic Res Cardiol 95 2000 389 396
25. J.D. Port, and M.R. Bristow Adrenergic receptor coupling and uncoupling in heart failure A. Richard, M.D. Walsh, Molecular mechanisms for cardiac hypertrophy and failure 2005 Taylor and Francis London and New York 323 340
26. W. Wang, W. Zhu, S. Wang, D. Yang, M.T. Crow, and R.P. Xiao Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway Circ Res 95 2004 798 806 (Pubitemid 39390582)
27. C.L. Zhang, T.A. McKinsey, S. Chang, C.L. Antos, J.A. Hill, and E.N. Olson Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy Cell 110 2002 479 488 (Pubitemid 35232291)
28. C.C. Sucharov, S. Langer, M. Bristow, and L. Leinwand Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A Am J Physiol Cell Physiol 291 2006 C1029 C1037
29. B. Illi, C. Dello Russo, C. Colussi, J. Rosati, M. Pallaoro, and F. Spallotta Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling Circ Res 102 2008 51 58
30. C.H. Ha, J.Y. Kim, J. Zhao, W. Wang, B.S. Jhun, and C. Wong PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy Proc Natl Acad Sci U S A 107 2010 15467 15472
31. M. Gloerich, and J.L. Bos EPAC: defining a new mechanism for cAMP action Annu Rev Pharmacol Toxicol 50 2010 355 375